PUBLISHER: The Business Research Company | PRODUCT CODE: 1948224
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948224
Smart infusion pumps are sophisticated upgrades of conventional infusion pumps, equipped with software and sometimes integrated connectivity features aimed at improving the safety and efficiency of medication administration. These devices come with advanced functionalities such as drug libraries, alert systems, and other intelligent technologies that help minimize human errors and enhance the precision of drug delivery.
The primary categories of smart infusion pumps include large volumetric infusion pumps, patient-controlled analgesia pumps, syringe infusion systems, electronic ambulatory infusion systems, implantable infusion systems, MRI-compatible IV infusion pump systems, disposable elastomeric infusion systems, and others. Among these, large volumetric infusion pumps are specifically engineered to administer high volumes of fluids, medications, or nutrients into the patient's bloodstream at regulated flow rates. These devices utilize various technologies such as digital infusion systems, smart pump platforms, wireless connectivity, traditional infusion mechanisms, and closed-loop controls. They are widely used across multiple medical disciplines such as oncology or chemotherapy, pediatrics or neonatology, gastroenterology, hematology, diabetes care, and others, and are employed in diverse healthcare environments, including hospitals, ambulatory surgical centers, home healthcare, specialty clinics, and more.
Tariffs are impacting the smart infusion pumps market by increasing the cost of imported electronic components, sensors, and smart pump modules. Segments like digital infusion systems, wireless infusion pumps, and MRI-compatible pumps are particularly affected, with Asia-Pacific regions such as China and India seeing higher import duties. This has led to increased production costs and potential delays in deployment. On the positive side, tariffs encourage local manufacturing, investment in domestic supply chains, and innovation in cost-effective smart pump solutions.
The smart infusion pumps market research report is one of a series of new reports from The Business Research Company that provides smart infusion pumps market statistics, including smart infusion pumps industry global market size, regional shares, competitors with a smart infusion pumps market share, detailed smart infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the smart infusion pumps industry. This smart infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The smart infusion pumps market size has grown strongly in recent years. It will grow from $8.88 billion in 2025 to $9.73 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to reliance on standard infusion pumps, limited integration with hospital IT systems, growing oncology and pediatric patient base, increasing hospital and clinic infrastructure, adoption of single-channel volumetric pumps.
The smart infusion pumps market size is expected to see strong growth in the next few years. It will grow to $13.84 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to development of multi-channel and programmable infusion systems, integration with electronic medical records (EMR), rising demand for home care infusion therapies, adoption of MRI-compatible and wireless infusion pumps, increasing use of digital and smart pump technologies. Major trends in the forecast period include rising adoption of smart pump technology, integration of wireless and closed-loop infusion systems, increasing use in home care and ambulatory settings, focus on reducing medication errors and enhancing patient safety, expansion of infusion pumps in specialty clinics and oncology.
The rise in chronic diseases is expected to drive the growth of the smart infusion pumps market in the coming years. Chronic diseases are long-term conditions that develop over time and typically require ongoing care or management. The growing prevalence of such conditions is largely attributed to increasingly sedentary lifestyles, which contribute to obesity, diabetes, and cardiovascular disorders. Smart infusion pumps play a critical role in managing chronic diseases by delivering precise and automated doses of medication, thereby reducing human error and improving long-term treatment outcomes. For example, in April 2025, the International Diabetes Federation (IDF), a Belgium-based non-profit organization, reported that nearly 589 million adults aged 20-79 are living with diabetes worldwide, a figure projected to increase significantly to 853 million by 2050. This rising incidence of chronic disease is thus fueling the demand for smart infusion pumps.
Companies operating in the smart infusion pumps market are prioritizing innovation, particularly through the development of cassette-based infusion pumps that aim to enhance medication delivery accuracy, improve patient safety, and streamline clinical workflows. Cassette-based infusion pumps use disposable cassettes to administer fluids or medications with high precision. For instance, in August 2023, ICU Medical Inc., a U.S.-based medical technology company, received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its Plum Duo infusion pump, which is integrated with the cloud-based LifeShield software. The pump features dual-channel delivery for simultaneous administration of two compatible intravenous therapies, thereby improving workflow efficiency and patient care. It also incorporates advanced drug library integration and automated programming to minimize medication errors. The LifeShield software enhances the pump with real-time monitoring, data-driven insights, and clinical decision support, which together ensure higher infusion safety and adherence to hospital protocols.
In September 2023, Abbott Laboratories, a U.S.-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed sum. This acquisition is intended to strengthen Abbott's diabetes care offerings by integrating Bigfoot Biomedical's smart insulin management technology with its FreeStyle Libre continuous glucose monitoring system. This integration aims to deliver a more comprehensive and connected solution for patients who require insulin. Bigfoot Biomedical Inc. is a U.S.-based company specializing in the development of smart infusion pumps.
Major companies operating in the smart infusion pumps market are Fresenius Kabi AG, Medtronic plc, Becton Dickinson and Company, Baxter International Inc, Terumo Corporation, Mindray Medical International Limited, Moog Inc, ICU Medical Inc, Insulet Corporation, Avanos Medical Inc, JMS Co Ltd, Vygon SA, B Braun Melsungen AG, Eitan Group, Heka Healthcare B V, PROMECON GmbH, Micrel Medical Devices SA, Smiths Medical, Zyno Medical LLC, CME Medical, Bionical Emas, Nipro Corporation
North America was the largest region in the smart infusion pumps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the smart infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The smart infusion pumps market includes revenues earned by entities by providing services such as equipment installation, maintenance, software updates, user training, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart infusion pumps market also includes sales of infusion pump units, syringes, pole clamps, and mounting hardware. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Smart Infusion Pumps Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses smart infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for smart infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart infusion pumps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.